Paydirt
RA
Insider

Raymond Anderson

Director · Monopar Therapeutics

Raymond Anderson (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $204K of MNPR (1,802 sh × $113.05, as filed), executed Aug 25. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$513K
shares × price, as filed
Last traded
Nov 2
Filed Nov 4

Median ADV $24.7M across their filed names

Open performance→
Volume by month
$407K$204K$0Dec 2024Jun 2025Dec 2025Jun 2026Aug 2026 · sells $407KNov 2026 · sells $105K
Buys $0 Sells $513K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
MNPR Monopar Therapeutics Inc. MNPR · 0 buys · 3 sells 3 filings
Recent filings
MNPRSALE Monopar Therapeutics Inc. View filing → $105K
1,502 sh × $70.04
Exec Nov 2
Filed Nov 4 · 8:15 PM ET MNPRSALE Monopar Therapeutics Inc. View filing → $204K
1,802 sh × $113.05
Exec Aug 25
Filed Aug 28 · 7:41 PM ET † MNPRSALE Monopar Therapeutics Inc. View filing → $204K
1,802 sh × $113.05
Exec Aug 25
Filed Aug 27 · 6:27 PM ET